Comparison · NCT04060667-sae
Intervention vs Control: serious adverse events
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Intervention vs Control: serious adverse events. Trial comparisons, record NCT04060667-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04060667-sae
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.00387 | 0.00177 | 0.00841 | wilson | |
| Risk in group 2 | 0.00737 | 0.00422 | 0.0128 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0035 | -0.00935 | 0.00203 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.525 | 0.197 | 1.39 | log | |
| Odds ratio, group 1 over group 2 | 0.523 | 0.196 | 1.4 | log | |
| Number needed to treat, for one fewer participant with a serious adverse event on Intervention than on Control | 286 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: control.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Intervention | Wireless physiologic monitoring: The intervention in this study is the use of a wireless monitor to perform physiologic monitoring of women undergoing emergency cesarean delivery for the first 24 hours after completion of the cesarean and send alerts to responding clinicians should vital signs fall out of a pre-specified range. | 6 | 1,552 | EG000 |
| Group 2 | Control | Standard of Care monitoring | 12 | 1,629 | EG001 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, serious adverse events
- Time frame
- Until hospital discharge, an average of 3 days
Source ClinicalTrials.gov
Trial
- Title
- Wireless Physiologic Monitoring in Postpartum Women
- NCT number
- NCT04060667
- Phases
- NA
- Conditions
- Maternal Death During Childbirth, Pregnancy Complications
- Interventions
- Wireless physiologic monitoring
- Lead sponsor
- Massachusetts General Hospital
- Results first posted
- 2025-09-09
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT04060667?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT04060667-sae